Skip to main content
Top
Published in: Head & Neck Oncology 1/2011

Open Access 01-12-2011 | Review

Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature

Authors: Pavel Komínek, Ivo Stárek, Marie Geierová, Petr Matoušek, Karol Zeleník

Published in: Head & Neck Oncology | Issue 1/2011

Login to get access

Abstract

Background

Oncogenous osteomalacia (OOM), which is also known as tumour-induced osteomalacia, is a rare condition associated with a neoplasm and a related systemic bone demineralization caused by renal phosphate wasting. OOM usually occurs in association with a variety of different mesenchymal tumours, and they were categorized into four distinct morphological patterns which they termed "phosphaturic mesenchymal tumour". Of its 4 histopathological subtypes, the mixed connective tissue variant is most commonly observed. Only 10% of cases appear in the head and neck regions and moreover, only 5 previously published tumors were localized in the sinonasal area. The authors describe a case of a man with a PMT originating from the frontoethmoidal region.

Case presentation

A 53-year-old man was referred to our ORL clinic due to a presence of a mass at the nasal root having been growing asymptomatically for 1 year. CT scans demonstrated a large (25 × 20 × 35 mm) bilateral frontoethmoidal mass with destruction of nasal bones. The tumor did not appear to invade to the anterior skull base. A selective angiography revealed a moderate hypervascularization of the tumour during early and late arterial phases. The tumour was removed from the external approach and the definitive histopathological diagnosis was a phospaturic mesenchymal tumor. Dual energy X-ray absorptiometry revealed a slight osteopenia of the first and second lumbar vertebrae and neck of the thigh bone. The serum and urinary levels of both calcium and anorganic phosphate were within normal limits. The patient is doing well three years after the operation, and the serum and urine levels of calcium and phosphate remain well within normal limits.

Conclusion

PMT is rare in the sinonasal region, it can be rarely observed without the signs of osteomalacia.
Appendix
Available only for authorised users
Literature
1.
go back to reference McCance RA: Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to Vitamin D acquired about the age of 15 years. Quart J Med. 1947, 16: 33-46.PubMed McCance RA: Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to Vitamin D acquired about the age of 15 years. Quart J Med. 1947, 16: 33-46.PubMed
2.
go back to reference Koriyama N, Nishimoto K, Kodama T, et al: Oncogenic osteomalacia in a case with maxillary sinus mesenchymal tumor. J Med Sci. 2006, 332 (4): 141-147. Koriyama N, Nishimoto K, Kodama T, et al: Oncogenic osteomalacia in a case with maxillary sinus mesenchymal tumor. J Med Sci. 2006, 332 (4): 141-147.
3.
go back to reference Williams K, Flanagan A, Folpe A, et al: Lymphatic vessels are present in phosphaturic mesenchymal tumours. Wirchows Arch. 2007, 451: 871-875. 10.1007/s00428-007-0471-y.CrossRef Williams K, Flanagan A, Folpe A, et al: Lymphatic vessels are present in phosphaturic mesenchymal tumours. Wirchows Arch. 2007, 451: 871-875. 10.1007/s00428-007-0471-y.CrossRef
4.
go back to reference Weidner N, Santa Cruz D: Phosphaturic mesenchymal tumours. A polymorphous group causing osteomalacia or rickets. Cancer. 1987, 59: 1442-1454. 10.1002/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q.CrossRefPubMed Weidner N, Santa Cruz D: Phosphaturic mesenchymal tumours. A polymorphous group causing osteomalacia or rickets. Cancer. 1987, 59: 1442-1454. 10.1002/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q.CrossRefPubMed
5.
go back to reference Folpe AL, Fanburg-Smith JC, Billlings SD, et al: Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity, the "phosphaturic mesenchymal tumor, mixed connective tissue variant": An analysis of 32 cases and a comprehensive review of the literature. Am J Surg. 2004, 28: 1-30. 10.1097/00000478-200401000-00001. Folpe AL, Fanburg-Smith JC, Billlings SD, et al: Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity, the "phosphaturic mesenchymal tumor, mixed connective tissue variant": An analysis of 32 cases and a comprehensive review of the literature. Am J Surg. 2004, 28: 1-30. 10.1097/00000478-200401000-00001.
6.
go back to reference Gonzales-Compta X, Manos-Pujol M, Foglia-Fernandez M, et al: Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol. 1998, 112: 389-392. Gonzales-Compta X, Manos-Pujol M, Foglia-Fernandez M, et al: Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol. 1998, 112: 389-392.
7.
go back to reference Yun KI, Kim DH, Pyo SW: A Phosphaturic mesenchymal tumor of the floor of the mouth with oncognic osteomalacia: report of a case. J Oral Maxillofac Surg. 2009, 67: 402-405. 10.1016/j.joms.2008.01.007.CrossRefPubMed Yun KI, Kim DH, Pyo SW: A Phosphaturic mesenchymal tumor of the floor of the mouth with oncognic osteomalacia: report of a case. J Oral Maxillofac Surg. 2009, 67: 402-405. 10.1016/j.joms.2008.01.007.CrossRefPubMed
8.
go back to reference Linsey M, Smith W, Yamauchi H, Bernstein L: Nasopharyngeal angiofibroma presenting as adult osteomalacia: case report and review of the literature. Laryngoscope. 1983, 93: 1328-1331.PubMed Linsey M, Smith W, Yamauchi H, Bernstein L: Nasopharyngeal angiofibroma presenting as adult osteomalacia: case report and review of the literature. Laryngoscope. 1983, 93: 1328-1331.PubMed
9.
go back to reference Papotti M, Foschini MP, Isaia G, Rizzi G, Betts CM, Eusebi V: Hypophosphatemic oncogenic osteomalacia: report of three new cases. Tumori. 1988, 74: 599-607.PubMed Papotti M, Foschini MP, Isaia G, Rizzi G, Betts CM, Eusebi V: Hypophosphatemic oncogenic osteomalacia: report of three new cases. Tumori. 1988, 74: 599-607.PubMed
10.
go back to reference Kawai Y, Morimoto S, Sakaguchi K, Yoshino H, Yutsui T, Hirota S, et al: Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excertion of cAMP. J Bone Miner Metab. 2001, 19: 61-64. 10.1007/s007740170062.CrossRefPubMed Kawai Y, Morimoto S, Sakaguchi K, Yoshino H, Yutsui T, Hirota S, et al: Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excertion of cAMP. J Bone Miner Metab. 2001, 19: 61-64. 10.1007/s007740170062.CrossRefPubMed
11.
go back to reference Shimada T, Mizutani S, Muto T, et al: Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Ntl Acad Sci USA. 2001, 98: 6500-6505. 10.1073/pnas.101545198.CrossRef Shimada T, Mizutani S, Muto T, et al: Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Ntl Acad Sci USA. 2001, 98: 6500-6505. 10.1073/pnas.101545198.CrossRef
Metadata
Title
Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature
Authors
Pavel Komínek
Ivo Stárek
Marie Geierová
Petr Matoušek
Karol Zeleník
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2011
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-3-16

Other articles of this Issue 1/2011

Head & Neck Oncology 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine